Amarin Corp Plc (AMRN)

[funnygi2]

Agree Slev. Note that KM said that the "ROW" markets they intend to file in have an additional $1 billion sales potential. That would be in addition to:

-Europe - would $2 billion/yr be unrealistic, especially since KM revealed their EU pricing?
-China
-USA

So what would the normal BO multiple be on, say, sales of $3.5 billion/yr?

Oh, one other thing. A long time ago, in a galaxy not so far away, the vaunted Mr. Yee said that V, like Epadel in Japan, could become an OTC medication after patents expire (like Voltaren) and still show sales in the hundreds of millions a year.

15-20? Cheep-cheep.